Cargando…

Hippocampal and behavioral dysfunctions in a mouse model of environmental stress: normalization by agomelatine

Stress-induced alterations in neuronal plasticity and in hippocampal functions have been suggested to be involved in the development of mood disorders. In this context, we investigated in the hippocampus the activation of intracellular signaling cascades, the expression of epigenetic markers and pla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boulle, F, Massart, R, Stragier, E, Païzanis, E, Zaidan, L, Marday, S, Gabriel, C, Mocaer, E, Mongeau, R, Lanfumey, L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259995/ https://www.ncbi.nlm.nih.gov/pubmed/25423137 http://dx.doi.org/10.1038/tp.2014.125

Ejemplares similares

Effect of agomelatine on memory deficits and hippocampal gene expression induced by chronic social defeat stress in mice
por: Martin, Vincent, et al.
Publicado: (2017)

Hippocampal Neurogenesis, Depressive Disorders, and Antidepressant Therapy
por: Paizanis, Eleni, et al.
Publicado: (2007)

Brain plasticity and cognitive functions after ethanol consumption in C57BL/6J mice
por: Stragier, E, et al.
Publicado: (2015)

Effects of Alcohol and Cocaine in a Mutant Mouse Model of Predisposition to Post-Traumatic Stress Disorder
por: Paizanis, Eleni, et al.
Publicado: (2020)

Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes
por: Milanese, Marco, et al.
Publicado: (2013)

α(2)- and β(2)-Adrenoreceptor-Mediated Efficacy of the Atypical Antidepressant Agomelatine Combined With Gabapentin to Suppress Allodynia in Neuropathic Rats With Ligated Infraorbital or Sciatic Nerve
por: M’Dahoma, Saïd, et al.
Publicado: (2018)

Agomelatine for postpartum depression and breastfeeding
por: Xiao, Le
Publicado: (2021)

Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT(2C )receptor-dependent pathways
por: Tardito, Daniela, et al.
Publicado: (2010)

Agomelatine in the treatment of anhedonia, somatic symptoms, and sexual dysfunction in major depressive disorder
por: Huang, Juan, et al.
Publicado: (2023)

The Effect of Agomelatine Treatment on Diabetes-Induced Cognitive Impairments in Rats: Concomitant Alterations in the Hippocampal Neuron Numbers
por: Can, Özgür Devrim, et al.
Publicado: (2018)

Agomelatine: A novel melatonergic antidepressant
por: Manikandan, S
Publicado: (2010)

Efficacy and tolerability of agomelatine in the treatment of depression
por: Plesničar, Blanka Kores
Publicado: (2014)

Agomelatine Efficacy in the Night Eating Syndrome
por: Milano, Walter, et al.
Publicado: (2013)

A Model of Chronic Exposure to Unpredictable Mild Socio-Environmental Stressors Replicates Some Spaceflight-Induced Immunological Changes
por: Gaignier, Fanny, et al.
Publicado: (2018)

Increased 5-HT2C receptor editing predisposes to PTSD-like behaviors and alters BDNF and cytokines signaling
por: Règue, Mathilde, et al.
Publicado: (2019)

Environmental enrichment normalizes hippocampal timing coding in a malformed hippocampus
por: Hernan, Amanda E., et al.
Publicado: (2018)

Agomelatine and its therapeutic potential in the depressed patient
por: Kennedy, Sidney H, et al.
Publicado: (2007)

Agomelatine: The evidence for its place in the treatment of depression
por: Eser, Daniela, et al.
Publicado: (2010)

The Effect of Agomelatine in Behavioral and Psychological Symptoms of Dementia
por: Wang, Carol Sheei-Meei, et al.
Publicado: (2022)

Successful Treatment with Agomelatine in NES: A Series of Five Cases
por: Milano, W., et al.
Publicado: (2013)

Agomelatine prevents macrophage infiltration and brain endothelial cell damage in a stroke mouse model
por: Cao, Yiqiang, et al.
Publicado: (2021)

Hippocampal circuit dysfunction in the Tc1 mouse model of Down syndrome
por: Witton, J., et al.
Publicado: (2015)

Agomelatine: relief ensured at each and every stage of depression
por: Möller, Hans-Jurgen
Publicado: (2010)

A systematic review of agomelatine-induced liver injury
por: Freiesleben, Silka Dawn, et al.
Publicado: (2015)

Inhibitory effect of celecoxib on agomelatine metabolism in vitro and in vivo
por: He, Jiayang, et al.
Publicado: (2018)

Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice
por: Nadar, Jegan Sakthivel, et al.
Publicado: (2018)

Agomelatine: A Potential Multitarget Compound for Neurodevelopmental Disorders
por: Savino, Rosa, et al.
Publicado: (2023)

Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
por: Taylor, David, et al.
Publicado: (2014)

Agomelatine as monotherapy for major depression: an outpatient, open-label study
por: Pecenak, Jan, et al.
Publicado: (2013)

Agomelatine Protection in an LPS-Induced Psychosis-Relevant Behavior Model
por: Inanir, Sema, et al.
Publicado: (2015)

Agomelatine in the Treatment of Major Depressive Disorder: An Assessment of Benefits and Risks
por: Gahr, Maximilian
Publicado: (2014)

Profile of agomelatine and its potential in the treatment of generalized anxiety disorder
por: Levitan, Michelle Nigri, et al.
Publicado: (2015)

Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
Publicado: (2014)

Novel Conformationally Constrained Analogues of Agomelatine as New Melatoninergic Ligands
por: Rami, Marouan, et al.
Publicado: (2012)

Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis
por: Wang, Sheng-Min, et al.
Publicado: (2020)

Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine
por: Stein, Dan J.
Publicado: (2021)

Understanding the Mechanism of Antidepressant-Related Sexual Dysfunction: Inhibition of Tyrosine Hydroxylase in Dopaminergic Neurons after Treatment with Paroxetine but Not with Agomelatine in Male Rats
por: Santana, Yanira, et al.
Publicado: (2019)

Agomelatine or ramelteon as treatment adjuncts in glioblastoma and other M1- or M2-expressing cancers
por: Kast, Richard E.
Publicado: (2015)

Sexually Dimorphic Serotonergic Dysfunction in a Mouse Model of Huntington's Disease and Depression
por: Renoir, Thibault, et al.
Publicado: (2011)

Agomelatine as monotherapy for major depression: an outpatient, open-label study [Corrigendum]
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_voboeupsbdf7g60qq8hvi85fma